A new FDA strategy aims to get medicines to the market faster

    By
    -

    The FDA has chosen Eli Lilly and Regeneron to participate in a new pilot program aimed at speeding up the development and approval of domestic drug manufacturing facilities, CNBC reports.  The ini…


    Already an INSIDER? Sign in.